TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C

TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C

The aim of the research – to optimize the prediction of hepatic fibrosis (HF) progression rate in HIV-infected patients with chronic hepatitis C (CHC) based on a comprehensive assessment of general clinical, biochemical, immunological and molecular-genetic markers. Materials and methods. A cross-...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. M. Syzova, T. I. Koval, L. P. Kotsiubailo, O. H. Marchenko
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2019-06-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	HIV infection chronic hepatitis C liver fibrosis prognosis
Online Access:	http://zmj.zsmu.edu.ua/article/view/169093/169289
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019-05-01)

Comparative assessment of liver fibrosis in patients with HIV/chronic hepatitis C co-infection in different ethnic groups
by: Nazgul Sarsekeyeva, et al.
Published: (2016-10-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Diagnostic values of MMP-9 and TGF-1β in assessing the severity of liver fibrosis and the rate of its progression in patients with chronic hepatitis C GT 1 infection
by: H. V. Venytska, et al.
Published: (2023-07-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

Relationship of tea consumption with hepatic steatosis and fibrosis: findings from a longitudinal RaNCD cohort
by: Shaimaa A. Qaisar, et al.
Published: (2025-03-01)

MRI findings of confluent hepatic fibrosis caused by different etiologies
by: Dan Yu, et al.
Published: (2025-07-01)

Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
by: GONG Xiaoqian, et al.
Published: (2025-04-01)

Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study
by: Xiaoxian Yang, et al.
Published: (2025-03-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

Assessment of hepatic fibrosis in patients with rheumatoid arthritis on long-term methotrexate therapy using transient elastography
by: Abhishek Kumar, et al.
Published: (2018-01-01)

A study to assess hepatic steatosis and fibrosis in chronic hepatitis B patients with the help of non-invasive tests
by: Gaurav Singh, et al.
Published: (2025-07-01)

Are bone morphogenetic protein-7 (BMP-7) serum levels correlated with development of hepatic fibrosis?
by: Nazlim Aktug Demir, et al.
Published: (2014-05-01)

Assessment of liver fibrosis stage influence on clinical course of periodontal diseases in patients with chronic hepatitis C
by: О. М. Slaba, et al.
Published: (2017-08-01)

Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)

Serum Elabela Level as a Reliable Biomarker for Predicting of Liver Fibrosis in Iraqi Patients with Chronic Hepatitis C
by: Eham Amer Ali, et al.
Published: (2024-07-01)

Patients with chronic hepatitis B exhibiting significant inflammation and fibrosis should pay particular attention to the status of hepatic steatosis during antiviral therapy
by: Bingqing Yang, et al.
Published: (2025-05-01)

Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Gi-Ae Kim, et al.
Published: (2025-01-01)

Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway
by: Meiling Zhang, et al.
Published: (2024-11-01)

Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa
by: F. M. Chonco, et al.
Published: (2019-04-01)

Features of the course and outcomes of neonatal hepatitis of various etiologies
by: N. A. Efremova, et al.
Published: (2014-09-01)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023-10-01)

Adiponectin level and severity of liver fibrosis in patients chronic hepatitis C with metabolic syndrome
by: A. F. Novikova, et al.
Published: (2018-07-01)

Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests
by: Huiyul Park, et al.
Published: (2025-07-01)

Leonurine Attenuates CCl4-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway
by: Wang P, et al.
Published: (2025-07-01)

Effect of Allostatic Load on hepatic steatosis and fatty liver-associated liver fibrosis
by: Lei Zhang, et al.
Published: (2025-07-01)

HLA-G liver expression in chronically HIV/hepatitis C-coinfected individuals.
by: Fernando Crivelenti Vilar, et al.
Published: (2025-01-01)

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
by: Qiyao Wei, et al.
Published: (2025-02-01)

First living donor liver transplantation for congenital hepatic fi brosis in Azerbaijan
by: R. A. Mamedov, et al.
Published: (2017-06-01)

Comorbidity and multimorbidity in patients with chronic hepatitis C
by: Ya. E. Saranskaya, et al.
Published: (2022-10-01)

Morphological and ultrasound features of liver fibrosis in children with autoimmune hepatitis
by: V. S. Berezenko, et al.
Published: (2018-12-01)

MODERN METHODS FOR ESTIMATION OF LIVER FIBROSIS
by: E. V. Guschina, et al.
Published: (2015-08-01)

Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999–2018
by: Shuyin Duan, et al.
Published: (2024-12-01)

Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models
by: Chuan Jiang, et al.
Published: (2025-01-01)

Morphogenesis of the liver fibrosis development and progression in chronic hepatitis C
by: M. A. Shishkin
Published: (2015-04-01)

Clinical impact of hepatitis delta virus coinfection on liver fibrosis in hepatitis B patients: a population-based study
by: Sisi Yang, et al.
Published: (2025-08-01)

Cobalt exposure was associated with the risk of hepatic steatosis and advanced liver fibrosis based on a cross-sectional study from NHANES
by: Ling Zhang, et al.
Published: (2025-03-01)

ACTUAL PRINCIPLES OF THERAPY CHRONIC HEPATITIS OF VARIOUS ETIOLOGIES
by: I. V. Semenova, et al.
Published: (2015-12-01)